Tue, Aug 20 2:26pm

Regenxbio Inc [RGNX]
$36.51 1.03 (2.74%)

RGNX Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.37 Billion
RGNX Description

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

Visit Website

RGNX Earnings

EPS -0.04 P/E Ratio 28.68
Previous Earnings Tue, May 7, 2019
Latest Earnings Wed, Aug 7, 2019 (13 days ago) -11.17%

RGNX Dividend

Yield --
Ex-Date --
Pay Date --
History --

RGNX Charts

1 Year
Aug 15, 2019
Sep 14, 2018

Symbol Price Day % YTD %
RGNX $36.51 -2.74% -15.74%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy